Loading...
XHKG
1302
Market cap734mUSD
Oct 09, Last price  
1.35HKD
1D
3.05%
1Q
-3.57%
Jan 2017
-27.42%
IPO
440.00%
Name

LifeTech Scientific Corp

Chart & performance

D1W1MN
XHKG:1302 chart
P/E
34.28
P/S
3.70
EPS
0.03
Div yield, %
—
Shrs. gr., 5y
0.13%
Rev. gr., 5y
16.35%
Revenues
1.37b
+5.07%
104,704,000140,324,000181,475,000231,035,000282,679,000311,606,000352,849,000409,125,000556,698,000668,879,000642,299,000925,334,0001,097,310,0001,267,175,0001,303,699,0001,369,779,000
Net income
148m
-33.53%
3,936,00011,830,00032,352,000-65,666,000-81,244,0002,359,000145,652,000163,472,000121,082,000129,200,000216,085,000292,472,000325,337,000263,242,000222,388,000147,827,000
CFO
555m
+72.65%
44,755,00011,790,00042,523,00034,963,00019,527,000144,313,000126,956,000154,891,000182,300,000274,986,000338,532,000488,853,000388,318,000418,049,000321,460,000555,014,953

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

LifeTech Scientific Corporation, an investment holding company, develops, manufactures, and trades in interventional medical devices for cardiovascular and peripheral vascular diseases and disorders in Mainland China, Europe, Rest of Asia, India, South America, Africa, and internationally. It operates through Structural Heart Diseases Business, Peripheral Vascular Diseases Business, and Cardiac Pacing and Electrophysiology Business segments. The company’s products include LAmbre left atrial appendage closure systems, as well as CeraFlex, Cera, HeartR, and Konar-MF VSD occluders; Ankura thoracic aortic aneurysm and abdominal aortic aneurysm stent graft systems; Futhrough endovascular needle systems; delivery systems, such as Fustar steerable and SteerEase introducers; Zoetrack guidewire; Aegisy vena cava filters; Cera vascular plug systems; AcuMark sizing balloons; HearTone implantable cardiac pacing system; and SeQure snare systems, as well as pacemakers. It also involved in the biomedical research and development; properties leasing business; and developing, manufacturing, and trading of medical devices, as well as offers technical, consulting, and technology services. LifeTech Scientific Corporation was founded in 1999 and is headquartered in Shenzhen, China.

Key people

Yuehui Xie
Executive Chairman of the Board, Chief Executive Officer · since 2015
Jiangbo Han
Chief Operating Officer · since 2014
Deyuan Zhang
Chief Scientist · since 2019
Jianxiong Joseph Liu
Chief Financial Officer, Executive Director, Company Secretary · since 2015
Mark Cibuzar
Overseas Sales Director
Sajeevan Manikkoth
India Sales Director
Guowei Zhan
Domestic Sales Director
Feng Fu
Non-Executive Director · since 2019
Feng Jiang
Non-Executive Director · since 2014
Hsien-Tse Liang
Non-Executive Independent Director · since 2011
Wansong Wang
Non-Executive Independent Director · since 2016
Luming Zhou
Independent Non-Executive Director · since 2014
IPO date
Nov 10, 2011
Employees
1,393
Domiciled in
CN
Incorporated in
KY
Headquarters & legal address
Box 309 Ugland House
Grand Cayman KY1-1104
KY
Address
阿格兰德大厦309号邮政信箱
大开曼岛 KY1-1104
KY
Other language
LifeTech Scientific Corporation

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT